Vorinostat and Combination Chemotherapy Before Donor Stem Cell Transplantation for the Treatment of Relapsed Aggressive B-cell or T-cell Non-Hodgkin Lymphoma

Clinical trial NCT04220008 · WITHDRAWN

Trial details

NCT number: NCT04220008
Sponsor: M.D. Anderson Cancer Center
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Aggressive Non-Hodgkin Lymphoma Recurrent B-Cell Non-Hodgkin Lymphoma Recurrent Burkitt Lymphoma Recurrent Diffuse Large B-Cell Lymphoma Recurrent High Grade B-Cell Lymphoma Recurrent T-Cell Non-Hodgkin Lymphoma Recurrent Transformed B-Cell Non-Hodgkin Lymphoma

Start date: 2021-10-29
Primary completion: 2021-10-29
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.